Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Urban (Vienna, Austria), M. Breyer (Vienna, Austria), R. Breyer-Kohansal (Vienna, Austria), A. Ofenheimer (Vienna, Austria), S. Hartl (Vienna, Austria), O. Burghuber (Vienna, Austria). Microvascular coronary perfusion and hyperinflation in COPD – data from the LEAD (Lung, hEart, sociAl, boDy) study. 3617

Member's Comments

No comment yet.

Related content which might interest you: Lung perfusion in pulmonary hypertension – results from the RESPIRE study Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Coronary artery calcification, epicardial fat burden, and cardiovascular events in COPD Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Lung volume reduction coils (LVR-coils) for pulmonary emphysema: Results of the Italian National registry Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 An open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study Source: Eur Respir J 2012; 39: 846-854 Year: 2012 Open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH) Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Pulmonary vessels remodeling in COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients Source: International Congress 2014 – ILDs 6 Year: 2014 Cardiopulmonary MR characteristics can estimate mPAP in COPD Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Pulmonary hypertension in COPD: results from the ASPIRE registry Source: Eur Respir J 2013; 41: 1292-1301 Year: 2013 In a general population there seems to be a link between subclinical atherosclerosis and lung hyperinflation Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Pulmonary artery to aorta ratio and mortality risk in the general population: The Rotterdam study Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016 Radiographic pulmonary vessel volume, lung function and airways disease in the Framingham Heart Study Source: Eur Respir J, 54 (3) 1900408; 10.1183/13993003.00408-2019 Year: 2019 Clinical meaning of low DLCO in idiopathic pulmonary arterial hypertension (IPAH) - Prospective single centre study Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Impact of COPD in patients with coronary heart disease submitted to coronary heart bypass graft Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Central vascular pressure measurements during exercise in COPD: How to handle the respirophasic changes? Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced COPD Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Atorvastatin in Pulmonary Arterial Hypertension (APATH) study Source: Eur Respir J 2012; 40: 67-74 Year: 2012 Cardiopulmonary exercise test (CPET) may show initial right cardiac dysfunction in patients with moderate-severe chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Best abstracts in physical activity and exercise testing Year: 2014